Keylika

Backed By Please support us by upvoting! Thanks Play Our first product is a novel drug (new molecular entity) in a skin patch to treat Iron Deficiency Anemia, with significantly improved safety, efficacy and tolerability. When approved, Keylika’s proprietary transdermal iron will be the world’s first prescription iron patch. Transdermal Iron Patch (NistuFe) New molecular … Home Read More »